Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine

This study has been completed.
Sponsor:
Collaborator:
Reckitt Benckiser Pharmaceuticals Inc.
Information provided by:
University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00679458
First received: May 14, 2008
Last updated: January 6, 2010
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)